Publication: Precision Cancer Diagnostics: Tracking Genomic Evolution in Clinical Trials
Loading...
Open/View Files
Date
2016
Authors
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Public Library of Science
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Beca, Francisco, and Andrew H. Beck. 2016. “Precision Cancer Diagnostics: Tracking Genomic Evolution in Clinical Trials.” PLoS Medicine 13 (12): e1002177. doi:10.1371/journal.pmed.1002177. http://dx.doi.org/10.1371/journal.pmed.1002177.
Abstract
In a Perspective, Francisco Beca and Andrew Beck discuss Charles Swanton and colleagues' accompanying Research Article on somatic mutations in patients with inflammatory breast cancer treated in a Phase II clinical trial.
Description
Other Available Sources
Research Data
Keywords
Medicine and Health Sciences, Oncology, Cancers and Neoplasms, Breast Tumors, Breast Cancer, Cancer Treatment, Biology and Life Sciences, Genetics, Genomics, Genomic Medicine, Medicine and health sciences, Clinical medicine, Clinical trials, Phase II clinical investigation, Pharmacology, Drug research and development, Human Genomics, Clinical Medicine, Clinical Trials, Clinical Trials (Cancer Treatment), Drug Research and Development, Molecular Biology, Molecular Biology Techniques, Sequencing Techniques, Genome Sequencing, Inflammatory Diseases
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service